All News
Primary Care Visits Decline 2008-2016
A national claims-based analysis has shown a consistent decline, by commercially insured adults (18-64 yrs), in primary care physician visits from 2008 to 2016; with nearly one half having no PCP visits in a given year by 2016.
Read Article
"In the course of my life, I have often had to eat my words, and I must confess that I have always found it a wholesome diet." -Winston Churchill
Dr. John Cush RheumNow ( View Tweet)
THe QD Clinic compilation Podcast 70-72 https://t.co/F11j7F4tZZ
Links:
Dr. John Cush RheumNow ( View Tweet)
RheumNow Podcast is up! Cool stuff and quips from the RWCS meeting! Watch the video here https://t.co/F8tS8nkLLB or listen to it on iTunes or here https://t.co/F11j7F4tZZ
Links:
Dr. John Cush RheumNow ( View Tweet)
COPA - multiple auto antibodies, ILD in kids. Genetic testing needed to Dx. https://t.co/RcLUhi6piJ
Dr. John Cush RheumNow ( View Tweet)
Engagement in sports increased odds of OA. Dr Wm Bugbee at #RWCS2020 @RWCSmtg https://t.co/HGh4jkF3HF
Dr. John Cush RheumNow ( View Tweet)
Important acronyms in both Ortho and Rheum. Dr Wm Bugbee at #RWCS2020 @RWCSmtg https://t.co/guqjPwkoFT
Dr. John Cush RheumNow ( View Tweet)
Primary immunodeficiency warning signs in adults; 25% of OID will develop an autoimmune disease. Dr Anna Postolova at #RWCS2020 @RWCSmtg https://t.co/c84Sybg95W
Dr. John Cush RheumNow ( View Tweet)
Dr. Anna Postolova @StanfordHealth outlines key warning signs for primary #immunodeficiency among children and adults: “25% of patients with PID will develop an #autoimmune disease” #RWCS2020 https://t.co/VWYYO6gMpR https://t.co/jjsiZnNuO6
Healio Rheumatology HealioRheum ( View Tweet)
Primary immune deficiency syndrome is more common than you think in autoimmune diseases. Conversely 25% of in nine deficiency pts have an autoimmune disease. Think repeated infections and allergies in your pts @RWCSmtg @RheumNow #RWCS2020 https://t.co/iXOf6G9wCD
Janet Pope Janetbirdope ( View Tweet)
Do you work up pt with frequent infections who has RA SLE or vasculitis? Common variable immune deficiency is .....COMMON @RWCSmtg @RheumNow #RWCS2020 https://t.co/CNHsayBst5
Janet Pope Janetbirdope ( View Tweet)
If asthma and allergies ask about atopic dermatitis. Most are kid onset but continue or recur in adulthood. Tip atopic dermatitis can increase with TNFis. New Rx and JAKis are entering this disease too. George Martin #RWCS2020 @RheumNow https://t.co/HqU05h5Vkb
Janet Pope Janetbirdope ( View Tweet)
Dr. Postolova recommends checking immunoglobulins and flow cytometry on every patient prior to starting RTX. #RWCS2020 @RheumNow @RWCSmtg
Dr. Rachel Tate uptoTate ( View Tweet)
Sarcoid and CVID can look alike as both get Granulomatous lessons. Dr Anna Postolova at #RWCS2020 @RWCSmtg https://t.co/TREQwYYrgc
Dr. John Cush RheumNow ( View Tweet)
A high percentage of complement deficiencies will develop lupus. Dr Anna Postolova at #RWCS2020 @RWCSmtg https://t.co/IItg1Ezd3F
Dr. John Cush RheumNow ( View Tweet)
Common immunodeficies. Dr Anna Postolova at #RWCS2020 @RWCSmtg https://t.co/rpjrmcl8t6
Dr. John Cush RheumNow ( View Tweet)
Was are placebo responses so high in RA MTX-IR who receive MTX in RCTs. ?adherence ?placebo effect ?keen study personnel. Filgo vs Ada - both effective and not stat different but high placebo too added to MTX. #RWCS2020 @RWCSmtg @RheumNow https://t.co/hHPR9yO0gb
Janet Pope Janetbirdope ( View Tweet)
Fewer VTE and HZ in filgotinib trials. More studies needed for proof of efficacy. Drs. Fleischmann and Genovese. #RWCS2020 @RheumNow @RWCSmtg https://t.co/O50yPwTxmm
Dr. Rachel Tate uptoTate ( View Tweet)
Here’s what I think is missing in RA for JAKi trials. Mono therapy post MTX-IR vs TNFi. Comparisons head2head with other biological and post JAKi RCT of another JAKi. @RWCSmtg @RheumNow #RWCS2020 #JAK
Janet Pope Janetbirdope ( View Tweet)
Fenebrutinib, a BTK inhibitor, is better that placebo, but not ADA when given in a phase 2 trial. Drs. Fleischman/Genovese at #RWCS2020 @RWCSmtg https://t.co/lOtFoB80s3
Dr. John Cush RheumNow ( View Tweet)